228 related articles for article (PubMed ID: 15359657)
21. Rituximab therapy in a patient with autoimmune hemolytic anemia and immune thrombocytopenia associated with chronic lymphocytic leukemia.
Aleem A
Ann Saudi Med; 2008; 28(5):382-5. PubMed ID: 18779631
[No Abstract] [Full Text] [Related]
22. [Successful treatment with rituximab for autoimmune hemolytic anemia associated with chronic lymphocytic leukemia].
Tanaka Y; Ito Y; Yoshizawa S; Fujimoto H; Gotoh M; Tauchi T; Kimura Y; Ohyashiki K
Rinsho Ketsueki; 2013 Feb; 54(2):229-31. PubMed ID: 23470833
[TBL] [Abstract][Full Text] [Related]
23. Mixed-type autoimmune haemolytic anaemia: unusual cases and a case associated with splenic T-cell angioimmunoblastic non-Hodgkin's lymphoma.
Win N; Tiwari D; Keevil VL; Needs M; Lakhani A
Hematology; 2007 Apr; 12(2):159-62. PubMed ID: 17454198
[TBL] [Abstract][Full Text] [Related]
24. Alemtuzumab to treat refractory autoimmune hemolytic anemia or thrombocytopenia in chronic lymphocytic leukemia.
Osterborg A; Karlsson C; Lundin J
Curr Hematol Malig Rep; 2009 Jan; 4(1):47-53. PubMed ID: 20425438
[TBL] [Abstract][Full Text] [Related]
25. Remission of severe antiphospholipid syndrome associated with non-Hodgkin's B-cell lymphoma after combined treatment with rituximab and chemotherapy.
Veneri D; Ambrosetti A; Franchini M; Mosna F; Poli G; Pizzolo G
Haematologica; 2005 Nov; 90 Suppl():ECR37. PubMed ID: 16266928
[TBL] [Abstract][Full Text] [Related]
26. Intensive chemotherapy with rituximab is safe and effective in AIDS non-Hodgkin's lymphoma.
Rey J; Charbonnier A; Schiano de Colella JM; Stoppa AM; Poizot-Martin I; Gastaut JA; Costello RT
AIDS; 2003 Sep; 17(13):2006-7. PubMed ID: 12960844
[No Abstract] [Full Text] [Related]
27. Rituximab therapy of severe aplastic anemia induced by fludarabine and cyclophosphamide in a patient affected by B-cell chronic lymphocytic leukemia.
Castiglioni MG; Scatena P; Pandolfo C; Mechelli S; Bianchi M
Leuk Lymphoma; 2006 Sep; 47(9):1985-6. PubMed ID: 17065021
[No Abstract] [Full Text] [Related]
28. Autoimmune myelitis in a CLL patient undergoing treatment with ibrutinib.
Wanner D; Bohn JP; Rudzki J; Stockhammer G; Steurer M
Ann Hematol; 2019 Jan; 98(1):205-207. PubMed ID: 29804266
[No Abstract] [Full Text] [Related]
29. Positive HIV ELISA test, autoimmune hemolytic anemia, and generalized lymphadenopathy: a unifying diagnosis.
Castillo JJ; Sinclair N; Stachurski D; Jacobsen ED
Am J Hematol; 2011 Aug; 86(8):690-3. PubMed ID: 21630306
[No Abstract] [Full Text] [Related]
30. Cocirculating precursor B acute lymphoblastic leukemia and chronic lymphocytic leukemia.
Huang Q
Blood; 2013 Sep; 122(13):2148. PubMed ID: 24195124
[No Abstract] [Full Text] [Related]
31. Optimal First-Line Therapy for Previously Untreated Chronic Lymphocytic Leukemia: The Case for Chemotherapy.
Brown JR
Oncology (Williston Park); 2015 Jun; 29(6):442, 444. PubMed ID: 26091679
[No Abstract] [Full Text] [Related]
32. Anti-CD20 therapy for chronic lymphocytic leukemia-associated autoimmune diseases.
Zaja F; Vianelli N; Sperotto A; Patriarca F; Tani M; Marin L; Tiribelli M; Candoni A; Baccarani M; Fanin R
Leuk Lymphoma; 2003 Nov; 44(11):1951-5. PubMed ID: 14738149
[TBL] [Abstract][Full Text] [Related]
33. Treatment of severe autoimmune hemolytic anemia in B-cell chronic lymphocytic leukemia with alemtuzumab.
Royer B; Vaida I; Etienne A; Garidi R; Damaj G; Marolleau JP
Leukemia; 2007 Aug; 21(8):1841-2; author reply 1842-3. PubMed ID: 17460703
[No Abstract] [Full Text] [Related]
34. Immune anaemias in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab--incidence and predictors.
Borthakur G; O'Brien S; Wierda WG; Thomas DA; Cortes JE; Giles FJ; Kantarjian HM; Lerner S; Keating MJ
Br J Haematol; 2007 Mar; 136(6):800-5. PubMed ID: 17341265
[TBL] [Abstract][Full Text] [Related]
35. Sequential development of monoclonal B cell lymphocytosis-derived small lymphocytic lymphoma and plasma cell leukemia.
Suzuki Y; Koya J; Ebisawa K; Abe H; Shinozaki-Ushiku A; Nakamura F; Kurokawa M
Ann Hematol; 2018 May; 97(5):917-919. PubMed ID: 29417202
[No Abstract] [Full Text] [Related]
36. Comparison of chlorambucil and prednisone versus cyclophosphamide, vincristine, and prednisone as initial treatment for chronic lymphocytic leukemia: long-term follow-up of an Eastern Cooperative Oncology Group randomized clinical trial.
Raphael B; Andersen JW; Silber R; Oken M; Moore D; Bennett J; Bonner H; Hahn R; Knospe WH; Mazza J
J Clin Oncol; 1991 May; 9(5):770-6. PubMed ID: 2016618
[TBL] [Abstract][Full Text] [Related]
37. Fludarabine-induced hemolytic anemia: successful treatment by rituximab.
Paydas S
Hematol J; 2004; 5(1):81-3. PubMed ID: 14745435
[TBL] [Abstract][Full Text] [Related]
38. Rituximab in heavily pretreated cutaneous B-cell lymphoma.
Zinzani PL; Stefoni V; Alinari L; Vianelli N; Baccarani M
Leuk Lymphoma; 2003 Sep; 44(9):1637-8. PubMed ID: 14565673
[No Abstract] [Full Text] [Related]
39. Response to fludarabine in B-cell chronic lymphocytic leukemia patients previously treated with chlorambucil as up-front therapy and a CHOP-like regimen as second line therapy.
Liso V; Molica S; Capalbo S; Pogliani E; Battista C; Broccia G; Montillo M; Cuneo A; Leoni P; Specchia G; Castoldi G
Haematologica; 2001 Nov; 86(11):1165-71. PubMed ID: 11694402
[TBL] [Abstract][Full Text] [Related]
40. Fludarabine-induced autoimmune hemolytic anemia in a CLL patient: rituximab as the treatment of choice?
Smolej L
Leuk Res; 2007 Feb; 31(2):267; author reply 268-9. PubMed ID: 16716397
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
